Skip to content
10-Q

Quarterly Report

MAIA BIOTECHNOLOGY, INC. MAIA

0001493152-26-022154

← back to feed
Filed
May 11, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 11, 2026 60.8M sh
Shares Diluted Q1 2026 · Mar 31, 2026 45.21M sh
Shares Diluted Q1 2026 · Mar 31, 2025 27.7M sh
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$5.31M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$4.2M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $0
Cash And Equivalents Q1 2026 · Dec 31, 2025 $0
Stockholders Equity Q1 2026 · Mar 31, 2026 $27.76M
Stockholders Equity Q1 2026 · Dec 31, 2025 $2.38M
Stockholders Equity Q1 2026 · Mar 31, 2025 $4.94M
Stockholders Equity Q1 2026 · Dec 31, 2024 $3.63M
Current Liabilities Q1 2026 · Mar 31, 2026 $6.32M
Current Liabilities Q1 2026 · Dec 31, 2025 $5.84M
Total Liabilities Q1 2026 · Mar 31, 2026 $7.56M
Total Liabilities Q1 2026 · Dec 31, 2025 $7.33M
Current Assets Q1 2026 · Mar 31, 2026 $35.32M
Current Assets Q1 2026 · Dec 31, 2025 $9.7M
Total Assets Q1 2026 · Mar 31, 2026 $35.32M
Total Assets Q1 2026 · Dec 31, 2025 $9.7M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.14
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.16
Eps Basic Q1 2026 · Mar 31, 2026 −$0.14
Eps Basic Q1 2026 · Mar 31, 2025 −$0.16
Sga Expense Q1 2026 · Mar 31, 2026 $3.42M
Sga Expense Q1 2026 · Mar 31, 2025 $2.23M
Rd Expense Q1 2026 · Mar 31, 2026 $43.65K
Net Income Q1 2026 · Mar 31, 2026 −$6.37M
Net Income Q1 2026 · Mar 31, 2025 −$4.52M
Operating Income Q1 2026 · Mar 31, 2026 −$6.95M
Operating Income Q1 2026 · Mar 31, 2025 −$5.43M